AdvaMed 2008: Day One Coverage

The OneMedPlace team is busy down in Washington, D.C. at AdvaMed 2008 capturing content from a host of presenting companies. For full coverage, check out OneMedTV. Highlights include: David VanAvermaete from Veralight presents a new approach to non-invasive diabetes screening through earlier detection and...

GI Dynamics’ EndoBarrier Could Disrupt Gastric Bypass Surgery Market

According to the American Society for Bariatric Surgery, doctors perform 140,000 gastric bypass surgeries in the United States each year. The most common types are Roux-en-Y gastric bypass and Laparoscopic Adjustable Gastric Banding. About 1% of patients who are candidates for gastric bypass surgery actually...

NovaDel Investors Restless as FDA Extends Approval Timeframe for Zolpimist

The FDA has requested an extension of “up to three months” in order to complete the review of the NovaDel’s Zolpimist Oral Spray for the short-term treatment of insomnia. The FDA will reply on or before December 19, 2008. NovaDel shares, which opened at $.28, traded as low as $.20 today. Following...

[Video Profile] Arterial Remodeling Technologies

Arterial Remodeling Technologies (ART) is developing bioresorbable peripheral and coronary polymer stents that promote the natural remodeling of an injured artery after angioplasty. ART’s bioresorbable stents provide the requisite mechanical scaffolding to resist initial recoil . Because of their...

Biolase: Checking In on the Turnaround

In February, I reported that a turnaround at Biolase was underway. Improved relations with Henry Schein, a key distributor, were largely responsible for the upturn. The company achieved fourth-quarter sales of more than $20 million – a record for Biolase and well ahead of analysts’ $17.4 million...

Elemé Medical to Launch SmoothShapes Internationally

As the bane of women the world over, treatment for cellulite is a healthcare holy grail. Elemé Medical has developed the FDA-cleared SmoothShapes system, a proprietary technology (dubbed Photomology) to treat the underlying causes of cellulite. Photomology combines laser energy with mechanical massage and...

Spectranetics: FDA Voices Concern Over SALVAGE Trial Safety

Spectranetics can’t catch a break. The Colorado Springs-based manufacturers of excimer lasers saw its share price plummet after the Fed issued search warrants so that it can investigate the company’s sales and marketing practices, among other things. Now the company’s Salvage Trial, a...

2008 Health Tech Investment Forum: Bringing Together Investors and Technology Providers

The Health Tech Investment Forum, taking place Tuesday, September 30th in NYC, will bring together some of the biggest names in healthcare technology. The one day conference will provide an opportunity for investors and healthcare leaders to discover the latest trends and investment opportunities. In 2007,...